274 related articles for article (PubMed ID: 3418520)
1. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
2. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
Maxwell DM; Koplovitz I
J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
[TBL] [Abstract][Full Text] [Related]
3. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
Maxwell DM; Brecht KM; O'Neill BL
Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
[TBL] [Abstract][Full Text] [Related]
4. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
[TBL] [Abstract][Full Text] [Related]
6. Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman.
Heyl WC; Harris LW; Stitcher DL
Drug Chem Toxicol; 1980; 3(3):319-32. PubMed ID: 7449657
[TBL] [Abstract][Full Text] [Related]
7. The role of carboxylesterase in species variation of oxime protection against soman.
Maxwell DM; Brecht KM
Neurosci Biobehav Rev; 1991; 15(1):135-9. PubMed ID: 2052186
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
[TBL] [Abstract][Full Text] [Related]
9. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Herkert NM; Thiermann H; Worek F
Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
Harris LW; Lennox WJ; Talbot BG; Anderson DR; Swanson DR
Drug Chem Toxicol; 1984; 7(5):507-26. PubMed ID: 6510256
[TBL] [Abstract][Full Text] [Related]
11. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
[TBL] [Abstract][Full Text] [Related]
12. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
13. [Prevention and treatment of status epilepticus induced by soman].
Blanchet G; Carpentier P; Lallement G; Sentenac-Roumanou H
Ann Pharm Fr; 1994; 52(1):11-24. PubMed ID: 8085742
[TBL] [Abstract][Full Text] [Related]
14. Protection of guinea pigs against soman poisoning by pretreatment with p-nitrophenyl phosphoramidates.
Langenberg JP; De Jong LP; Benschop HP
Toxicol Appl Pharmacol; 1996 Oct; 140(2):444-50. PubMed ID: 8887462
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
Buccafusco JJ; Li W
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
[TBL] [Abstract][Full Text] [Related]
16. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
[TBL] [Abstract][Full Text] [Related]
17. Role of aliesterase in organophosphate poisoning.
Clement JG
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
Harris LW; Anderson DR; Pastelak AM; Vanderpool B
Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
[TBL] [Abstract][Full Text] [Related]
19. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
Lennox WJ; Harris LW; Talbot BG; Anderson DR
Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
von Bredow JD; Adams NL; Groff WA; Vick JA
Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
